The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor
Not Applicable
- Conditions
- type 2 diabetes mellitus hypertension
- Registration Number
- JPRN-UMIN000004925
- Lead Sponsor
- Department of Internal Medicine, School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1. type 1 diabetes mellitus 2. Patients who take both ACE inhibitor and ARB 3. Ptients who have allergy to the study drugs 4. Severe hypertension (180/110 mmHg or higher) 5. Pregnant women, women who want to be pregnant 6. Patients taking cyclosporine 7. Sever liver dysfunction (GOT>80 IU/L, GPT>80 IU/L), renal dysfunction (Cr>1.5(male), 1.4 (female) mg/dl)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The value of HbA1c at the endopoitn of the trial
- Secondary Outcome Measures
Name Time Method